Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹21 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr
Mar2021₹75 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr
-82.91
Mar2021 ₹75 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,583.2 Cr -0.3% -2.3% 19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.3%

-2.3%

19.5%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses